Keywords: پریزامینید; Metabolomics; Tuberculosis; Pyrazinamide; Purine metabolism; First-line anti-tuberculosis drugs; Prediction;
مقالات ISI پریزامینید (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: پریزامینید; Pyrazinamide; Cyclic peptide nanotube; Density functional theory; Hydrogen bond; Atom in molecules; Natural bond orbital;
Keywords: پریزامینید; ALG; alginate; Cm; capreomycin; CHI; chitosan; DPIs; dry powder inhalers; E; ethambutol; EC; ethyl cellulose; ECM; extracellular matrix; Eto; ethionamide; FPF; fine particle fraction; HA; hyaluronic acid; HIP/PCA; hydrophobic ion-pairing/precipitation wit
Keywords: پریزامینید; Inos; Isoprinosine; INH; Isoniazid; RIF; Rifampicin; PYZ; Pyrazinamide; ETH; Ethambutol; CFU; Colony Forming Units;
Keywords: پریزامینید; Line probe assay; Mycobacterium tuberculosis; pncA; Pyrazinamide; Resistance;
Keywords: پریزامینید; Tuberculosis; Pyrazinamide; Pharmacokinetics; Human immunodeficiency virus; Point-of-care testing;
Keywords: پریزامینید; Pyrazinamide; Dermis; Microdialysis; Pharmacokinetics; Leishmaniasis; Rats;
Keywords: پریزامینید; tuberculosis; fixed dose combination; isonicotinyl hydrazone; isoniazid; pyrazinamide; rifampicin; ethambutol dihydrochloride;
Keywords: پریزامینید; Pyrazinamide; Moxifloxacin; l-leucine; 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine; Spray drying; Inhalation;
Keywords: پریزامینید; cutaneous tuberculosis; disseminated tuberculosis; pyrazinamide; treatment duration;
Keywords: پریزامینید; antitubercular agents; isoniazid; rifampicin; pyrazinamide; oxidative stress; complementary therapies;
Keywords: پریزامینید; Pyrazinamide; Gas electron diffraction; Regularization; Amount of information; Heuristic criterion; Quantum chemistry; 00-01; 99-00;
Keywords: پریزامینید; HIV; human immunodeficiency virus; TB; tuberculosis; FBDD; fragment-based drug discovery; HTS; high-throughput screening; SPR; surface plasmon resonance; Mtb; Mycobacterium tuberculosis; Mab; Mycobacterium abscessus; INH; isoniazid; PZA; pyrazinamide; NTM
Recent advancements in the development of anti-tuberculosis drugs
Keywords: پریزامینید; ADRs; adverse drug reactions; AG; arabinogalactan; AhpE; alkylhydroperoxide reductase E; Alr; d-alanine racemase; AMP; adenosine monophosphate; AnPRT; anthranilate phosphoribosyltransferase; ATP; adenosine triphosphate; BTZ; benzothiazinone; CADD; compute
Keywords: پریزامینید; Tuberculosis; Pyrazinamide; Pyrazinoic acid; Resistance; Wayne; Bactec; TEMA; Optic density; pncA; Peru;
Keywords: پریزامینید; Hepatotoxicity; latent tuberculosis infection; levofloxacin; multidrug-resistant tuberculosis; pyrazinamide; QuantiFERON-TB Gold In-Tube
Keywords: پریزامینید; Alzheimer's disease; Azetidinones; Acetylcholinestrase inhibitor; Pyrazinamide
Keywords: پریزامینید; Pyrazinamide; Graphene; Zinc oxide nanoparticles; Differential pulse voltammetry; Pharmaceutical samples
Keywords: پریزامینید; Mycobacterium tuberculosis; Pyrazinamide; pncA gene; DNA sequencing;
Keywords: پریزامینید; Reduced graphene oxide; Bimetallic nanodendrite; Pyrazinamide; Imprinted sensor; Real sample analysis
Keywords: پریزامینید; AR antagonist; Molecular modeling; Bioisostere; Nicotinamide; Pyrazinamide; Pyrimidinamide
Keywords: پریزامینید; BID; twice daily; CBC; complete blood cell count; CDC; Centers for Disease Control and Prevention; CNS; central nervous system; CYP3A4; cytochrome P450 3A4; DOT; directly observed therapy; DST; drug susceptibility testing; ECG; electrocardiogram; HIV; hum
Keywords: پریزامینید; Pyrazinamide; Ethionamide; Square-wave voltammetry; Poly(l-Cys)/GCE; Simultaneous determination;
Keywords: پریزامینید; Pyrazinamide; Susceptibility testing
Keywords: پریزامینید; Pyrazinamide; Tetrahydropyrimidines; Biginelli reaction; Acetyl cholinesterase inhibitor
Keywords: پریزامینید; acid-fast bacilli; ethambutol; interferon-γ-release assay; isoniazid; latent TB; multidrug-resistant TB; pyrazinamide; rifampin; tuberculin skin test; tuberculosis
Keywords: پریزامینید; Tuberculosis; Pyrazinamide; Lung delivery; Aerodynamic properties; Pharmacokinetics;
Keywords: پریزامینید; Rifampicin; Ethambutol; Pyrazinamide; Drug penetration; Pericardium; Protein binding
Keywords: پریزامینید; Brij 96; Calorimetry (DSC); Preformulation; Nile red; rifampicin; isoniazid; pyrazinamide; Fluorescence spectroscopy; Microemulsions; UV/Vis Spectroscopy;
Keywords: پریزامینید; Multidrug-resistant tuberculosis; pncA; pyrazinamide; sensitivity and specificity;
Keywords: پریزامینید; Pyrazinamide; Tuberculosis; HPLC; Liquid-liquid extraction; Isocratic mode;
Keywords: پریزامینید; Tuberculosis; Pyrazinamide; Large porous particle; Lung delivery; Crystallization;
Keywords: پریزامینید; Isoniazid; Rifampicin; Ethambutol; Pyrazinamide; MTT assay; Ames test;
Use of chemometrics to compare NIR and HPLC for the simultaneous determination of drug levels in fixed-dose combination tablets employed in tuberculosis treatment
Keywords: پریزامینید; Near-infrared spectroscopy; Rifampicin; Isoniazid; Pyrazinamide; Ethambutol; Fixed-dose combination (FDC);
The influence of surface active l-leucine and 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine (DPPC) in the improvement of aerosolization of pyrazinamide and moxifloxacin co-spray dried powders
Keywords: پریزامینید; Pyrazinamide; Moxifloxacin HCl; l-Leucine; 1,2-Dipalmitoyl-sn-glycero-3-phosphatidylcholine; Surface composition; Aerodynamic performance;
Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China
Keywords: پریزامینید; Multidrug resistance; Mycobacterium tuberculosis; panD; pncA; Pyrazinamide; rpsA;
Temperature dependent polymorphism of pyrazinamide: An in situ Raman and DFT study
Keywords: پریزامینید; Pyrazinamide; Tuberculosis; Hydrogen bonding; Raman spectroscopy; DFT;
Anti-Mycobacterium tuberculosis activity of essential oil and 6,7-dehydroroyleanone isolated from leaves of Tetradenia riparia (Hochst.) Codd (Lamiaceae)
Keywords: پریزامینید; Mycobacterium tuberculosis; Tetradenia riparia; Essential oil; Antimycobacterial activity; Cytotoxicity; TB; Tuberculosis; HIV; human immunodeficiency virus; MDR; multidrug-resistant; XDR; extensively drug-resistant; TrEO; Tetradenia riparia essential oil
Structural and quantum mechanical computations to elucidate the altered binding mechanism of metal and drug with pyrazinamidase from Mycobacterium tuberculosis due to mutagenicity
Keywords: پریزامینید; Mycobacterium tuberculosis; Pyrazinamidase; Pyrazinamide; Mutagenicity; Quantum mechanics; DFT; Molecular docking;
Genotypic characterization of pyrazinamide resistance in Mycobacterium tuberculosis isolated from Lusaka, Zambia
Keywords: پریزامینید; Pyrazinamide; pncA; Resistance; Mutation; BACTEC MGIT 960;
Dissecting whole-genome sequencing-based online tools for predicting resistance in Mycobacterium tuberculosis: can we use them for clinical decision guidance?
Keywords: پریزامینید; Multidrug-resistant tuberculosis; Whole-genome sequencing; TB profiler; TGS-TB; PhyResSE; Mykrobe predictor; AMK; Amikacin; CAP; Capreomycin; CICLO; Cicloserine; DST; Drug Susceptibility Testing; EMB; Etambutol; ETH; Ethionamide; FLQ; Fluoroquinolones; IG
In vitro activity of collinin isolated from the leaves of Zanthoxylum schinifolium against multidrug- and extensively drug-resistant Mycobacterium tuberculosis
Keywords: پریزامینید; Collinin; Zanthoxylum schinifolium; MDR; XDR; Mycobacterium tuberculosis; ATCC; American type culture collection; ADC; albumin dextrose catalase; CFU; colony forming unit; CLSI; clinical and laboratory standards institute; DMEM; dulbecco's modified eagle
Performance of a highly successful outbreak strain of Mycobacterium tuberculosis in a multifaceted approach to bacterial fitness assessment
Keywords: پریزامینید; CFU; colony forming units; DTH; delayed-type hypersensitivity; EMB; ethambutol; INH; isoniazid; IS6110-RFLP; restriction fragment length polymorphism based on insertion sequence 6110; KAN; kanamycin; MDM; human monocyte-derived macrophages; MDR; multidrug
1H NMR spectral identification of medication in cerebrospinal fluid of pediatric meningitis
Keywords: پریزامینید; proton nuclear magnetic resonance (1H NMR); cerebrospinal fluid (CSF); pyrazinamide; isoniazid; acyclovir; sulfamethoxazole;
Modalités de traitement de la tuberculose
Keywords: پریزامینید; chimioprophylaxie antituberculeuse; éthambutol; infection tuberculose latente; isoniazide; pyrazinamide; rifampicine; tuberculose; antituberculosis chemoprophylaxis; ethambutol; isoniazid; latent tuberculosis infection; pyrazinamide; rifampicin; tubercul
A nanodiamond-based electrochemical sensor for the determination of pyrazinamide antibiotic
Keywords: پریزامینید; Nanodiamond; Pyrazinamide; Electrochemical sensing; Urine; Human serum;
Different spectrophotometric and TLC-densitometric methods for determination of pyrazinamide in presence of its impurity
Keywords: پریزامینید; Pyrazinamide; Pyrazine-2-carboxylic acid; Third derivative; First derivative of ratio spectra; Mean centering of ratio spectra and TLC-densitometric method;
Pyrazinamide-induced hepatotoxicity is alleviated by 4-PBA via inhibition of the PERK-eIF2α-ATF4-CHOP pathway
Keywords: پریزامینید; Pyrazinamide; Endoplasmic reticulum (ER) stress; Hepatotoxicity; PERK-eIF2α-ATF4-CHOP pathway; Sodium 4-phenylbutyrate;
Detection of pyrazinamide resistance of Mycobacterium tuberculosis using nicotinamide as a surrogate
Keywords: پریزامینید; Microplate Alarmar Blue assay; Nicotinamide; Pyrazinamide; Susceptibility testing; Tuberculosis;
Simultaneous HPLC assay for pretomanid (PA-824), moxifloxacin and pyrazinamide in an inhaler formulation for drug-resistant tuberculosis
Keywords: پریزامینید; Pretomanid (PA-824); Moxifloxacin; Pyrazinamide; HPLC; Spray-dried powder for inhalation; l-leucine;